A carregar...

Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin

AIM: To assess the efficacy and safety of the combination of pegylated liposomal doxorubicin (PLD) and carboplatin in patients with recurrent epithelial ovarian carcinoma (ROC), following disease progression on single agent PLD. METHODS: An analysis of the medical records of 10 patients with ROC, tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Grenader, Tal, Rosengarten, Ora, Isacson, Rut, Plotkin, Yevgeni, Gabizon, Alberto
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3509111/
https://ncbi.nlm.nih.gov/pubmed/23198277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v3.i10.137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!